Navigation Links
Four Major Universities Join Nation's Leading Postgrad Bio Jobs Board
Date:5/12/2009

SANTA CRUZ, Calif., May 12 /PRNewswire/ -- Four prestigious universities have joined Bio Career Center, the nation's leading online jobs board and careers site for life science professionals.

UCLA, Brown, NYU and Georgetown are now members of the jobs board, joining 15 other major universities.

The jobs board, www.biocareercenter.com, is only for post-graduates in the life sciences. While there are hundreds of life science career sites on the Internet, Bio Career Center is the only one that serves life science post-graduates exclusively.

Bio Career Center's institution consortium consists of Stanford, Berkeley, Brown, Caltech, Emory, Georgetown, M.D. Anderson, Michigan State, New York University, Scripps Institute, University of California, Los Angeles, University of California at San Francisco, University of Colorado Denver, University of Miami, University of North Carolina Chapel Hill, University of Pennsylvania, University of Washington, Vanderbilt and Weill Cornell.

Developed with the Stanford Medical School director of career services, www.biocareercenter.com is constructed for P.h.D.s, M.D.s and other post-graduates who are looking for efficient ways to manage their careers. From industry articles and assessment tools to relevant job postings, Bio Career Center is a comprehensive and free career resource center. Job seekers have access to opportunities including academia, biopharmaceutical and government as well as vertical markets like consulting, public health and science policy.

Bio Career Center organizes qualified candidates to save recruiter
'/>"/>

SOURCE Bio Career Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Honeywell Technology Selected to Control Manufacturing Processes at Major U.S. Biotech Site
3. State-of-the-art electron microscope promises to aid major research advances
4. Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company
5. Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company
6. EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone
7. Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe
8. Hepatitis C Virus Patient Opportunity Exists Within Many of the Major U.S. Local Markets
9. On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
10. Encorium Group Signs $3.1 Million of New Business Contracts Including an Extension of a Current U.S. Oncology Clinical Trial with a Major Pharmaceutical Company
11. Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3